Results

Total Results: 1,492 records

Showing results for "mortality".
Users also searched for: falls in hospitals

21. Comparative Effectiveness of Antihypertensive Therapies on Cardiovascular Disease Outcomes In End-Stage Renal Disease | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/renal-disease-therapies/abstract
    December 01, 2019 - antihypertensive therapeutic regimen to improve cardiovascular disease (CVD)-related morbidity and mortality … ARBs), beta blockers, and calcium channel blockers on risk of cardiovascular outcomes (morbidity and mortality … ), all cause mortality, and other important patient outcomes (e.g., health-related quality of life). … comparative effectiveness of prescribed antihypertensive therapeutic regimens with all cause and CVD mortality … , CVD mortality, and morbidity compared to beta blockers and calcium channel blockers.

22. Making Healthcare Safer IV_Rapid Response: Use of Report Cards and Outcome Measurements To Improve the Safety of Surgical Care (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-surgical-report-cards.pdf
    November 01, 2023 - rates following coronary artery bypass graft (CABG) surgery (CABG).1 Data collected from this registry … The indicators most relevant to surgery are: • PSI 04 – Death rate among surgical inpatients with … Heart surgery death rates decline in New York. New York Times. December 5, 1990;Sect. B10. 4. … rates for a PIPS institution versus National Trauma Data Bank (NTDB), 2004-2009 Institution: 1 … Decrease general surgery mortality rate (3.5% to 1.7%; p=0.007).

23. Rapid Evidence Product_Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
    October 01, 2022 - rates MACE/MACCE. … nine SRs reported all-cause mortality rates (see Table 3). … Eight SRs reported CV mortality rates (see Table 3). … (2019)27 and Khan et al. (2021)26 both reported reduced CV mortality rates associated with CTO- PCI … Qian et al. (2022)28 did not report CV mortality rates.

24. Prostate-Cancer-Therapies-Update Executive (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_executive.pdf
    December 01, 2014 - Potential benefits of regular PSA screening include early cancer detection and reduced mortality rates … These outcomes include overall survival, all-cause mortality, prostate cancer– specific mortality, QOL … Table C summarizes our findings on overall survival, overall mortality, prostate cancer–specific mortality … reduction in all-cause mortality (but not prostate cancer–specific mortality) among men with PSA levels … PSA-detected prostate cancer; (2) compare patient-focused outcomes (e.g., all-cause and cancer-specific mortalities

25. Transitional Care Interventions To Prevent Readmissions for People With Heart Failure | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/heart-failure-transition-care/research
    December 01, 2019 - Home-visiting programs, MDS-HF clinics, and STS interventions produced a mortality benefit (moderate … Neither telemonitoring nor nurse-led clinic interventions reduced readmissions or mortality. … Components of interventions showing efficacy for reducing all-cause readmissions or mortality include … In general, categories of interventions that reduced all-cause readmissions or mortality were more likely … ; STS reduced HF-specific readmission and mortality but not all-cause readmission.

26. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - Mortality reductions may be limited to men age 65 and older and those with intermediate risk disease … and prostate cancer mortality over 12 years and late genitourinary toxicity over 3 years. … Prostate cancer mortality is infrequent in low-risk disease, and all-cause or prostate cancer mortality … Prostate cancer mortality and metastases were rare in all three groups. … We found no evidence for effects of photodynamic therapy on mortality or metastases.

27. Respectful Maternity Care: Dissemination and Implementation of Perinatal Safety Culture to Improve Equitable Maternal Healthcare Delivery and Outcomes | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/respectful-maternity-care/protocol
    October 01, 2022 - From 2018 to 2019, just ahead of the COVID-19 pandemic, maternal mortality rates in the US increased … rates persist for non-Hispanic Black women even when controlling for education, income, or socioeconomic … Maternal mortality rates in the United States, 2019 National Center for Health Statistics.  … Maternal mortality rates in the United States, 2020 National Center for Health Statistics.  … and case-fatality rates.

28. Thrombosis plays a a key role in the pathophysiology of myocardial infarction-a leading cause of morbidity and mortality. There have been a number of devices proposed for mechanical thrombectomy in patients with in the setting of acute… | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/thrombosis-plays-a-a-key-role-in-the-pathophysiology-of-myocardial-infarction-a-leading-cause-of-morbidity-and-mortality-there-have-been-a-number-of-devices-proposed-for-mechanical-thrombectomy-in-patients-with-in-the-settin
    November 01, 2017 - plays a a key role in the pathophysiology of myocardial infarction-a leading cause of morbidity and mortality … plays a a key role in the pathophysiology of myocardial infarction-a leading cause of morbidity and mortality … plays a a key role in the pathophysiology of myocardial infarction-a leading cause of morbidity and mortality … Improved morbidity and mortality (unsure whether there are long term studies, the few I saw looked primarily … plays a a key role in the pathophysiology of myocardial infarction-a leading cause of morbidity and mortality

29. Mortality Risk in Chronic Obstructive Pulmonary Disease Patients Using Theophylline | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/copd-management/research
    November 01, 2017 - Mortality was compared using Cox proportional hazards models and other outcomes were compared using negative … In comparisons of other regimens the risk of mortality associated with theophylline in the regimen was … to similar regimens, patients in regimens that included theophylline had slightly increased risks of mortality … Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary … PMID: 22048220 Project Timeline Mortality Risk in Chronic Obstructive Pulmonary

30. Layout 1 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
    October 01, 2006 - Although studies were generally too small to detect any but large differences in mortality rates, no … Very high mortality rates, over 40 percent within 6 years, occurred mostly in studies of patients with … Weak evidence suggests no difference in mortality rates with medical treatment alone or with angioplasty … Medical studies did not report mortality within 30 days of being followed. … It was evident, by comparing mortality rates or change in kidney function across studies, that the severity

31. Geographic Variation in Carotid Endarterectomy and Carotid Stenting Among Medicare Beneficiaries, 2003-2006 | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/cardiology-health-outcomes/research
    January 01, 2019 - We used Kaplan-Meier methods to calculate unadjusted 30-day and 1-year mortality rates. … Finally, the 30-day mortality rate for carotid endarterectomy (1.2%) in 2005 was lower than the rates … rate for carotid stenting (2.3%) was higher than the rates reported in the initial randomized trial … rates we observed and those reported in clinical trials are not unexpected. … Second, the absence of detailed clinical data prevented us from calculating risk-adjusted mortality rates

32. Geographic Variation in Carotid Endarterectomy and Carotid Stenting Among Medicare Beneficiaries, 2003-2006 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cardiology-health-outcomes_research.pdf
    July 01, 2010 - We used Kaplan-Meier methods to calculate unadjusted 30-day and 1-year mortality rates. … Finally, the 30-day mortality rate for carotid endarterectomy (1.2%) in 2005 was lower than the rates … rate for carotid stenting (2.3%) was higher than the rates reported in the initial randomized trial … rates we observed and those reported in clinical trials are not unexpected. … rates.

33. Executive Summary: Pain Management Interventions for Hip Fracture (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/cer30_hip-fracture-pain-executive-summary_20110517.pdf
    May 01, 2011 - Short­term mortality rates are high and range from 25 percent for women to 37 percent for men in the … Two RCTs reported 30­day mortality (n = 99) and found no statistically significant difference in mortality … rates (OR 1.73; 95% CI 0.53, 5.68; p = 0.36). … One cohort study (n = 182) reported that there was no significant difference in 30­day mortality rates … rate (see Table A).

34. Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/sodium-potassium/final-report-2018
    December 01, 2019 - , CVD morbidity and mortality, CHD morbidity and mortality, stroke, myocardial infarction, renal morbidity … and mortality, kidney stones, and adverse events. … Although sodium levels appear to be associated with all-cause mortality (low SoE), the shape of this … or CVD, stroke, or renal morbidity or mortality; the potential moderating effects of other factors, … that reducing sodium intake may decrease the risk for CVD morbidity and mortality.

35. Data Points 17: Trends in Bariatric Surgery: Trends in bariatric surgery in Medicare beneficiaries (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/bariatric-surgery-trends_research.pdf
    November 01, 2012 - Postoperative mortality is low. … Morbidity and mortality rates following bariatric surgery continue to be a major concern.7 Data Points … rates were low: under 1 percent for all operations at 30 days postoperation and 4 percent or less … in Medicare beneficiaries between 1997 and 2002.16 They found higher mortality rates—2.0 percent … mortality at 30 days and 4.6 percent mortality at one year.

36. 04-E029-1 Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
    December 01, 2011 - Collectively, they demonstrated decreases in the mortality rate for all age groups between the early … survival rates stratified by race/ethnicity, mortality rates among blacks were consistently higher compared … rates than men on WW. … rates than men on WW. … Studies also demonstrated decreases in the prostate cancer-specific mortality rate for all age groups

37. AHRQ Slide Template 2019-Widescreen
    effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/mhs-IV-epc-grand-rounds-slides.pptx
    January 01, 2023 - Systematic review & meta-analysis Hospital mortality Reduced mortality {RR=0.85; 95% CI, 0.76-0.94} Adults … Primary study Hospital mortality 27% reduction Adults Factora Primary study Hospital mortality 4% average … Primary Multi-pronged intervention to improve recognition and activation Hospital mortality, O/E mortality … Primary Patient management protocols Hospital mortality Significant mortality reductions Adults Factora … Primary Anesthesiology leadership and policy changes Hospital mortality Mortality improved (p<0.001)

38. Kidney-Disease-Medicine Executive (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
    January 01, 2012 - difference in risk of all-cause mortality, cardiovascular mortality, MI, or composite vascular outcomes … difference in risk of all-cause mortality … in risk of all-cause mortality, cardiovascular mortality, ESRD, or single composite vascular outcome … significant difference in risk of all-cause mortality … in risk of mortality

39. Effectiveness of Isosorbide Dinitrate and Hydralazine in Racial/Ethnic Subgroups With Heart Failure | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/congestive-heart-failure-medicines/research
    January 01, 2020 - Conclusions: H-ISDN was not associated with significant reduction in mortality or hospitalization for … We found no significant association between H-ISDN and mortality within racial/ethnic subgroups with … Pair-wise comparisons of racial/ethnic subgroups showed that the effects of H-ISDN on both mortality … Effect of vasodilator therapy on mortality in chronic congestive heart failure. … Accuracy and completeness of mortality data in the Department of Veterans Affairs.

40. Outcomes Associated With Tiotropium use in Chronic Obstructive Pulmonary Disease Patients | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/copd-anticholinergic-medicines/research
    January 01, 2020 - The crude mortality rate was 14.6 per 100 person-years in the tiotropium group and 11.7 per 100 person-years … For the most part, findings for exacerbations and hospitalizations were similar to mortality. … Accuracy and completeness of mortality data in the Department of Veterans Affairs. … Rate * RR Crude Exacerbation Rate * RR Crude Hospitalization Rate * RR ICS+LABA (Ref … Association between medication regimen and mortality, exacerbation, and hospitalization   Mortality